Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 2593 to 2603 of 2603 entries
Sorted by: Best Match Show Resources per page
Effect of Plasma-Treatment of Interleaved Thermoplastic Films on Delamination in Interlayer Fibre Hybrid Composite Laminates.

Polymers

Marino SG, Mayer F, Bismarck A, Czél G.
PMID: 33260510
Polymers (Basel). 2020 Nov 28;12(12). doi: 10.3390/polym12122834.

Safe, light, and high-performance engineering structures may be generated by adopting composite materials with stable damage process (i.e., without catastrophic delamination). Interlayer hybrid composites may fail stably by suppressing catastrophic interlayer delamination. This paper provides a detailed analysis of...

Cite
Marino SG, Mayer F, Bismarck A, et al. Effect of Plasma-Treatment of Interleaved Thermoplastic Films on Delamination in Interlayer Fibre Hybrid Composite Laminates. Polymers (Basel). 2020;12(12)doi: 10.3390/polym12122834.
Marino, S. G., Mayer, F., Bismarck, A., & Czél, G. (2020). Effect of Plasma-Treatment of Interleaved Thermoplastic Films on Delamination in Interlayer Fibre Hybrid Composite Laminates. Polymers, 12(12), . https://doi.org/10.3390/polym12122834
Marino, Salvatore Giacomo, et al. "Effect of Plasma-Treatment of Interleaved Thermoplastic Films on Delamination in Interlayer Fibre Hybrid Composite Laminates." Polymers vol. 12,12 (2020). doi: https://doi.org/10.3390/polym12122834
Marino SG, Mayer F, Bismarck A, Czél G. Effect of Plasma-Treatment of Interleaved Thermoplastic Films on Delamination in Interlayer Fibre Hybrid Composite Laminates. Polymers (Basel). 2020 Nov 28;12(12). doi: 10.3390/polym12122834. PMID: 33260510; PMCID: PMC7759880.
Copy Download .nbib Format: NLM
Perioperative outcome in groin hernia repair: what are the most important influencing factors?.

Hernia : the journal of hernias and abdominal wall surgery

Köckerling F, Adolf D, Lorenz R, Stechemesser B, Kuthe A, Conze J, Lammers B, Fortelny R, Mayer F, Zarras K, Reinpold W, Hoffmann H, Weyhe D.
PMID: 33895891
Hernia. 2021 Apr 24; doi: 10.1007/s10029-021-02417-5. Epub 2021 Apr 24.

INTRODUCTION: Using registry analyses, a large number of influencing factors on the perioperative outcome of groin hernia repair has been identified. The interactions between several influencing factors and differences in the influencing value have to date been inadequately investigated.METHODS:...

Cite
Köckerling F, Adolf D, Lorenz R, et al. Perioperative outcome in groin hernia repair: what are the most important influencing factors?. Hernia. 2021;doi: 10.1007/s10029-021-02417-5.
Köckerling, F., Adolf, D., Lorenz, R., Stechemesser, B., Kuthe, A., Conze, J., Lammers, B., Fortelny, R., Mayer, F., Zarras, K., Reinpold, W., Hoffmann, H., & Weyhe, D. (2021). Perioperative outcome in groin hernia repair: what are the most important influencing factors?. Hernia : the journal of hernias and abdominal wall surgery, . https://doi.org/10.1007/s10029-021-02417-5
Köckerling, F, et al. "Perioperative outcome in groin hernia repair: what are the most important influencing factors?." Hernia : the journal of hernias and abdominal wall surgery vol. (2021). doi: https://doi.org/10.1007/s10029-021-02417-5
Köckerling F, Adolf D, Lorenz R, Stechemesser B, Kuthe A, Conze J, Lammers B, Fortelny R, Mayer F, Zarras K, Reinpold W, Hoffmann H, Weyhe D. Perioperative outcome in groin hernia repair: what are the most important influencing factors?. Hernia. 2021 Apr 24; doi: 10.1007/s10029-021-02417-5. Epub 2021 Apr 24. PMID: 33895891.
Copy Download .nbib Format: NLM
Correction: Integrative analysis of genomic variants reveals new associations of candidate haploinsufficient genes with congenital heart disease.

PLoS genetics

Audain E, Wilsdon A, Breckpot J, Izarzugaza JMG, Fitzgerald TW, Kahlert AK, Sifrim A, Wünnemann F, Perez-Riverol Y, Abdul-Khaliq H, Bak M, Bassett AS, Benson DW, Berger F, Daehnert I, Devriendt K, Dittrich S, Daubeney PE, Garg V, Hackmann K, Hoff K, Hofmann P, Dombrowsky G, Pickardt T, Bauer U, Keavney BD, Klaassen S, Kramer HH, Marshall CR, Milewicz DM, Lemaire S, Coselli JS, Mitchell ME, Tomita-Mitchell A, Prakash SK, Stamm K, Stewart AFR, Silversides CK, Siebert R, Stiller B, Rosenfeld JA, Vater I, Postma AV, Caliebe A, Brook JD, Andelfinger G, Hurles ME, Thienpont B, Larsen LA, Hitz MP.
PMID: 34547032
PLoS Genet. 2021 Sep 21;17(9):e1009809. doi: 10.1371/journal.pgen.1009809. eCollection 2021 Sep.

[This corrects the article DOI: 10.1371/journal.pgen.1009679.].

Cite
Audain E, Wilsdon A, Breckpot J, et al. Correction: Integrative analysis of genomic variants reveals new associations of candidate haploinsufficient genes with congenital heart disease. PLoS Genet. 2021;17(9):e1009809doi: 10.1371/journal.pgen.1009809.
Audain, E., Wilsdon, A., Breckpot, J., Izarzugaza, J. M. G., Fitzgerald, T. W., Kahlert, A. K., Sifrim, A., Wünnemann, F., Perez-Riverol, Y., Abdul-Khaliq, H., Bak, M., Bassett, A. S., Benson, D. W., Berger, F., Daehnert, I., Devriendt, K., Dittrich, S., Daubeney, P. E., Garg, V., Hackmann, K., Hoff, K., Hofmann, P., Dombrowsky, G., Pickardt, T., Bauer, U., Keavney, B. D., Klaassen, S., Kramer, H. H., Marshall, C. R., Milewicz, D. M., Lemaire, S., Coselli, J. S., Mitchell, M. E., Tomita-Mitchell, A., Prakash, S. K., Stamm, K., Stewart, A. F. R., Silversides, C. K., Siebert, R., Stiller, B., Rosenfeld, J. A., Vater, I., Postma, A. V., Caliebe, A., Brook, J. D., Andelfinger, G., Hurles, M. E., Thienpont, B., Larsen, L. A., & Hitz, M. P. (2021). Correction: Integrative analysis of genomic variants reveals new associations of candidate haploinsufficient genes with congenital heart disease. PLoS genetics, 17(9), e1009809. https://doi.org/10.1371/journal.pgen.1009809
Audain, Enrique, et al. "Correction: Integrative analysis of genomic variants reveals new associations of candidate haploinsufficient genes with congenital heart disease." PLoS genetics vol. 17,9 (2021): e1009809. doi: https://doi.org/10.1371/journal.pgen.1009809
Audain E, Wilsdon A, Breckpot J, Izarzugaza JMG, Fitzgerald TW, Kahlert AK, Sifrim A, Wünnemann F, Perez-Riverol Y, Abdul-Khaliq H, Bak M, Bassett AS, Benson DW, Berger F, Daehnert I, Devriendt K, Dittrich S, Daubeney PE, Garg V, Hackmann K, Hoff K, Hofmann P, Dombrowsky G, Pickardt T, Bauer U, Keavney BD, Klaassen S, Kramer HH, Marshall CR, Milewicz DM, Lemaire S, Coselli JS, Mitchell ME, Tomita-Mitchell A, Prakash SK, Stamm K, Stewart AFR, Silversides CK, Siebert R, Stiller B, Rosenfeld JA, Vater I, Postma AV, Caliebe A, Brook JD, Andelfinger G, Hurles ME, Thienpont B, Larsen LA, Hitz MP. Correction: Integrative analysis of genomic variants reveals new associations of candidate haploinsufficient genes with congenital heart disease. PLoS Genet. 2021 Sep 21;17(9):e1009809. doi: 10.1371/journal.pgen.1009809. eCollection 2021 Sep. PMID: 34547032; PMCID: PMC8454942.
Copy Download .nbib Format: NLM
Detectable Unmetabolized Folic Acid and Elevated Folate Concentrations in Folic Acid-Supplemented Canadian Children With Sickle Cell Disease.

Frontiers in nutrition

Williams BA, Mayer C, McCartney H, Devlin AM, Lamers Y, Vercauteren SM, Wu JK, Karakochuk CD.
PMID: 33968971
Front Nutr. 2021 Apr 21;8:642306. doi: 10.3389/fnut.2021.642306. eCollection 2021.

Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a variant (rs344) in the

Cite
Williams BA, Mayer C, McCartney H, et al. Detectable Unmetabolized Folic Acid and Elevated Folate Concentrations in Folic Acid-Supplemented Canadian Children With Sickle Cell Disease. Front Nutr. 2021;8:642306doi: 10.3389/fnut.2021.642306.
Williams, B. A., Mayer, C., McCartney, H., Devlin, A. M., Lamers, Y., Vercauteren, S. M., Wu, J. K., & Karakochuk, C. D. (2021). Detectable Unmetabolized Folic Acid and Elevated Folate Concentrations in Folic Acid-Supplemented Canadian Children With Sickle Cell Disease. Frontiers in nutrition, 8642306. https://doi.org/10.3389/fnut.2021.642306
Williams, Brock A, et al. "Detectable Unmetabolized Folic Acid and Elevated Folate Concentrations in Folic Acid-Supplemented Canadian Children With Sickle Cell Disease." Frontiers in nutrition vol. 8 (2021): 642306. doi: https://doi.org/10.3389/fnut.2021.642306
Williams BA, Mayer C, McCartney H, Devlin AM, Lamers Y, Vercauteren SM, Wu JK, Karakochuk CD. Detectable Unmetabolized Folic Acid and Elevated Folate Concentrations in Folic Acid-Supplemented Canadian Children With Sickle Cell Disease. Front Nutr. 2021 Apr 21;8:642306. doi: 10.3389/fnut.2021.642306. eCollection 2021. PMID: 33968971; PMCID: PMC8096995.
Copy Download .nbib Format: NLM
Rapid establishment of a frontline field laboratory in response to an imported outbreak of Ebola virus disease in western Uganda, June 2019.

PLoS neglected tropical diseases

Schuh AJ, Kyondo J, Graziano J, Balinandi S, Kainulainen MH, Tumusiime A, Nyakarahuka L, Mulei S, Baluku J, Lonergan W, Mayer O, Masereka R, Masereka F, Businge E, Gatare A, Kabyanga L, Muhindo S, Mugabe R, Makumbi I, Kayiwa J, Wetaka MM, Brown V, Ojwang J, Nelson L, Millard M, Nichol ST, Montgomery JM, Taboy CH, Lutwama JJ, Klena JD.
PMID: 34860831
PLoS Negl Trop Dis. 2021 Dec 03;15(12):e0009967. doi: 10.1371/journal.pntd.0009967. eCollection 2021 Dec.

The Democratic Republic of the Congo (DRC) declared an Ebola virus disease (EVD) outbreak in North Kivu in August 2018. By June 2019, the outbreak had spread to 26 health zones in northeastern DRC, causing >2,000 reported cases and...

Cite
Schuh AJ, Kyondo J, Graziano J, et al. Rapid establishment of a frontline field laboratory in response to an imported outbreak of Ebola virus disease in western Uganda, June 2019. PLoS Negl Trop Dis. 2021;15(12):e0009967doi: 10.1371/journal.pntd.0009967.
Schuh, A. J., Kyondo, J., Graziano, J., Balinandi, S., Kainulainen, M. H., Tumusiime, A., Nyakarahuka, L., Mulei, S., Baluku, J., Lonergan, W., Mayer, O., Masereka, R., Masereka, F., Businge, E., Gatare, A., Kabyanga, L., Muhindo, S., Mugabe, R., Makumbi, I., Kayiwa, J., Wetaka, M. M., Brown, V., Ojwang, J., Nelson, L., Millard, M., Nichol, S. T., Montgomery, J. M., Taboy, C. H., Lutwama, J. J., & Klena, J. D. (2021). Rapid establishment of a frontline field laboratory in response to an imported outbreak of Ebola virus disease in western Uganda, June 2019. PLoS neglected tropical diseases, 15(12), e0009967. https://doi.org/10.1371/journal.pntd.0009967
Schuh, Amy J, et al. "Rapid establishment of a frontline field laboratory in response to an imported outbreak of Ebola virus disease in western Uganda, June 2019." PLoS neglected tropical diseases vol. 15,12 (2021): e0009967. doi: https://doi.org/10.1371/journal.pntd.0009967
Schuh AJ, Kyondo J, Graziano J, Balinandi S, Kainulainen MH, Tumusiime A, Nyakarahuka L, Mulei S, Baluku J, Lonergan W, Mayer O, Masereka R, Masereka F, Businge E, Gatare A, Kabyanga L, Muhindo S, Mugabe R, Makumbi I, Kayiwa J, Wetaka MM, Brown V, Ojwang J, Nelson L, Millard M, Nichol ST, Montgomery JM, Taboy CH, Lutwama JJ, Klena JD. Rapid establishment of a frontline field laboratory in response to an imported outbreak of Ebola virus disease in western Uganda, June 2019. PLoS Negl Trop Dis. 2021 Dec 03;15(12):e0009967. doi: 10.1371/journal.pntd.0009967. eCollection 2021 Dec. PMID: 34860831; PMCID: PMC8673597.
Copy Download .nbib Format: NLM
Transmission Dynamics of Large Coronavirus Disease Outbreak in Homeless Shelter, Chicago, Illinois, USA, 2020.

Emerging infectious diseases

Chang YS, Mayer S, Davis ES, Figueroa E, Leo P, Finn PW, Perkins DL.
PMID: 34856112
Emerg Infect Dis. 2022 Jan;28(1):76-84. doi: 10.3201/eid2801.210780. Epub 2021 Dec 02.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has the potential for rapid transmission in congregate settings. We describe the multidisciplinary response to an outbreak of coronavirus disease (COVID-19) in a large homeless shelter in Chicago, Illinois, USA. The response...

Cite
Chang YS, Mayer S, Davis ES, et al. Transmission Dynamics of Large Coronavirus Disease Outbreak in Homeless Shelter, Chicago, Illinois, USA, 2020. Emerg Infect Dis. 2021;28(1):76-84doi: 10.3201/eid2801.210780.
Chang, Y. S., Mayer, S., Davis, E. S., Figueroa, E., Leo, P., Finn, P. W., & Perkins, D. L. (2022). Transmission Dynamics of Large Coronavirus Disease Outbreak in Homeless Shelter, Chicago, Illinois, USA, 2020. Emerging infectious diseases, 28(1), 76-84. https://doi.org/10.3201/eid2801.210780
Chang, Yi-Shin, et al. "Transmission Dynamics of Large Coronavirus Disease Outbreak in Homeless Shelter, Chicago, Illinois, USA, 2020." Emerging infectious diseases vol. 28,1 (2022): 76-84. doi: https://doi.org/10.3201/eid2801.210780
Chang YS, Mayer S, Davis ES, Figueroa E, Leo P, Finn PW, Perkins DL. Transmission Dynamics of Large Coronavirus Disease Outbreak in Homeless Shelter, Chicago, Illinois, USA, 2020. Emerg Infect Dis. 2022 Jan;28(1):76-84. doi: 10.3201/eid2801.210780. Epub 2021 Dec 02. PMID: 34856112.
Copy Download .nbib Format: NLM
The Structure of the Electric Double Layer of the Protic Ionic Liquid [Dema][TfO] Analyzed by Atomic Force Spectroscopy.

International journal of molecular sciences

Rodenbücher C, Chen Y, Wippermann K, Kowalski PM, Giesen M, Mayer D, Hausen F, Korte C.
PMID: 34884462
Int J Mol Sci. 2021 Nov 23;22(23). doi: 10.3390/ijms222312653.

Protic ionic liquids are promising electrolytes for fuel cell applications. They would allow for an increase in operation temperatures to more than 100 °C, facilitating water and heat management and, thus, increasing overall efficiency. As ionic liquids consist of...

Cite
Rodenbücher C, Chen Y, Wippermann K, et al. The Structure of the Electric Double Layer of the Protic Ionic Liquid [Dema][TfO] Analyzed by Atomic Force Spectroscopy. Int J Mol Sci. 2021;22(23)doi: 10.3390/ijms222312653.
Rodenbücher, C., Chen, Y., Wippermann, K., Kowalski, P. M., Giesen, M., Mayer, D., Hausen, F., & Korte, C. (2021). The Structure of the Electric Double Layer of the Protic Ionic Liquid [Dema][TfO] Analyzed by Atomic Force Spectroscopy. International journal of molecular sciences, 22(23), . https://doi.org/10.3390/ijms222312653
Rodenbücher, Christian, et al. "The Structure of the Electric Double Layer of the Protic Ionic Liquid [Dema][TfO] Analyzed by Atomic Force Spectroscopy." International journal of molecular sciences vol. 22,23 (2021). doi: https://doi.org/10.3390/ijms222312653
Rodenbücher C, Chen Y, Wippermann K, Kowalski PM, Giesen M, Mayer D, Hausen F, Korte C. The Structure of the Electric Double Layer of the Protic Ionic Liquid [Dema][TfO] Analyzed by Atomic Force Spectroscopy. Int J Mol Sci. 2021 Nov 23;22(23). doi: 10.3390/ijms222312653. PMID: 34884462.
Copy Download .nbib Format: NLM
Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease: The Randomized, Double-blind, Placebo-Controlled ISAR-PLASTER Phase 2 Trial.

JAMA cardiology

Mayer K, Hein-Rothweiler R, Schüpke S, Janisch M, Bernlochner I, Ndrepepa G, Sibbing D, Gori T, Borst O, Holdenrieder S, Kupka D, Petzold T, Bradaric C, Okrojek R, Leistner DM, Trippel TD, Münzel T, Landmesser U, Pieske B, Zeiher AM, Gawaz MP, Hapfelmeier A, Laugwitz KL, Schunkert H, Kastrati A, Massberg S.
PMID: 33787834
JAMA Cardiol. 2021 Jul 01;6(7):753-761. doi: 10.1001/jamacardio.2021.0475.

IMPORTANCE: The assessment of new antithrombotic agents with a favorable safety profile is clinically relevant.OBJECTIVE: To test the efficacy and safety of revacept, a novel, lesion-directed antithrombotic drug, acting as a competitive antagonist to platelet glycoprotein VI.DESIGN, SETTING, AND...

Cite
Mayer K, Hein-Rothweiler R, Schüpke S, et al. Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease: The Randomized, Double-blind, Placebo-Controlled ISAR-PLASTER Phase 2 Trial. JAMA Cardiol. 2021;6(7):753-761doi: 10.1001/jamacardio.2021.0475.
Mayer, K., Hein-Rothweiler, R., Schüpke, S., Janisch, M., Bernlochner, I., Ndrepepa, G., Sibbing, D., Gori, T., Borst, O., Holdenrieder, S., Kupka, D., Petzold, T., Bradaric, C., Okrojek, R., Leistner, D. M., Trippel, T. D., Münzel, T., Landmesser, U., Pieske, B., Zeiher, A. M., Gawaz, M. P., Hapfelmeier, A., Laugwitz, K. L., Schunkert, H., Kastrati, A., & Massberg, S. (2021). Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease: The Randomized, Double-blind, Placebo-Controlled ISAR-PLASTER Phase 2 Trial. JAMA cardiology, 6(7), 753-761. https://doi.org/10.1001/jamacardio.2021.0475
Mayer, Katharina, et al. "Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease: The Randomized, Double-blind, Placebo-Controlled ISAR-PLASTER Phase 2 Trial." JAMA cardiology vol. 6,7 (2021): 753-761. doi: https://doi.org/10.1001/jamacardio.2021.0475
Mayer K, Hein-Rothweiler R, Schüpke S, Janisch M, Bernlochner I, Ndrepepa G, Sibbing D, Gori T, Borst O, Holdenrieder S, Kupka D, Petzold T, Bradaric C, Okrojek R, Leistner DM, Trippel TD, Münzel T, Landmesser U, Pieske B, Zeiher AM, Gawaz MP, Hapfelmeier A, Laugwitz KL, Schunkert H, Kastrati A, Massberg S. Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease: The Randomized, Double-blind, Placebo-Controlled ISAR-PLASTER Phase 2 Trial. JAMA Cardiol. 2021 Jul 01;6(7):753-761. doi: 10.1001/jamacardio.2021.0475. PMID: 33787834; PMCID: PMC8014195.
Copy Download .nbib Format: NLM
Dissociative Effects of Neuropeptide S Receptor Deficiency and Nasal Neuropeptide S Administration on T-Maze Discrimination and Reversal Learning.

Pharmaceuticals (Basel, Switzerland)

Bicakci AO, Tsai PL, Kahl E, Mayer D, Fendt M.
PMID: 34358069
Pharmaceuticals (Basel). 2021 Jul 05;14(7). doi: 10.3390/ph14070643.

Cognitive flexibility refers to the ability to modify learned behavior in response to changes in the environment. In laboratory rodents, cognitive flexibility can be assessed in reversal learning, i.e., the change of contingencies, for example in T-maze discrimination learning....

Cite
Bicakci AO, Tsai PL, Kahl E, et al. Dissociative Effects of Neuropeptide S Receptor Deficiency and Nasal Neuropeptide S Administration on T-Maze Discrimination and Reversal Learning. Pharmaceuticals (Basel). 2021;14(7)doi: 10.3390/ph14070643.
Bicakci, A. O., Tsai, P. L., Kahl, E., Mayer, D., & Fendt, M. (2021). Dissociative Effects of Neuropeptide S Receptor Deficiency and Nasal Neuropeptide S Administration on T-Maze Discrimination and Reversal Learning. Pharmaceuticals (Basel, Switzerland), 14(7), . https://doi.org/10.3390/ph14070643
Bicakci, Ahmet Oguzhan, et al. "Dissociative Effects of Neuropeptide S Receptor Deficiency and Nasal Neuropeptide S Administration on T-Maze Discrimination and Reversal Learning." Pharmaceuticals (Basel, Switzerland) vol. 14,7 (2021). doi: https://doi.org/10.3390/ph14070643
Bicakci AO, Tsai PL, Kahl E, Mayer D, Fendt M. Dissociative Effects of Neuropeptide S Receptor Deficiency and Nasal Neuropeptide S Administration on T-Maze Discrimination and Reversal Learning. Pharmaceuticals (Basel). 2021 Jul 05;14(7). doi: 10.3390/ph14070643. PMID: 34358069; PMCID: PMC8308873.
Copy Download .nbib Format: NLM
Psychosocial Moderators and Mediators of Sensorimotor Exercise in Low Back Pain: A Randomized Multicenter Controlled Trial.

Frontiers in psychiatry

Wippert PM, Niederer D, Drießlein D, Beck H, Banzer W, Schneider C, Schiltenwolf M, Mayer F.
PMID: 34393840
Front Psychiatry. 2021 Jul 29;12:629474. doi: 10.3389/fpsyt.2021.629474. eCollection 2021.

The effects of exercise interventions on unspecific chronic low back pain (CLBP) have been investigated in many studies, but the results are inconclusive regarding exercise types, efficiency, and sustainability. This may be because the influence of psychosocial factors on...

Cite
Wippert PM, Niederer D, Drießlein D, et al. Psychosocial Moderators and Mediators of Sensorimotor Exercise in Low Back Pain: A Randomized Multicenter Controlled Trial. Front Psychiatry. 2021;12:629474doi: 10.3389/fpsyt.2021.629474.
Wippert, P. M., Niederer, D., Drießlein, D., Beck, H., Banzer, W., Schneider, C., Schiltenwolf, M., & Mayer, F. (2021). Psychosocial Moderators and Mediators of Sensorimotor Exercise in Low Back Pain: A Randomized Multicenter Controlled Trial. Frontiers in psychiatry, 12629474. https://doi.org/10.3389/fpsyt.2021.629474
Wippert, Pia-Maria, et al. "Psychosocial Moderators and Mediators of Sensorimotor Exercise in Low Back Pain: A Randomized Multicenter Controlled Trial." Frontiers in psychiatry vol. 12 (2021): 629474. doi: https://doi.org/10.3389/fpsyt.2021.629474
Wippert PM, Niederer D, Drießlein D, Beck H, Banzer W, Schneider C, Schiltenwolf M, Mayer F. Psychosocial Moderators and Mediators of Sensorimotor Exercise in Low Back Pain: A Randomized Multicenter Controlled Trial. Front Psychiatry. 2021 Jul 29;12:629474. doi: 10.3389/fpsyt.2021.629474. eCollection 2021. PMID: 34393840; PMCID: PMC8358182.
Copy Download .nbib Format: NLM
SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Ruether DF, Schaub GM, Duengelhoef PM, Haag F, Brehm TT, Fathi A, Wehmeyer M, Jahnke-Triankowski J, Mayer L, Hoffmann A, Fischer L, Addo MM, Lütgehetmann M, Lohse AW, Schulze Zur Wiesch J, Sterneck M.
PMID: 34509643
Clin Gastroenterol Hepatol. 2021 Sep 09; doi: 10.1016/j.cgh.2021.09.003. Epub 2021 Sep 09.

BACKGROUND & AIMS: Detailed information on the immune response after second vaccination of cirrhotic patients and liver transplant (LT) recipients against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is largely missing. We aimed at comparing the vaccine-induced humoral...

Cite
Ruether DF, Schaub GM, Duengelhoef PM, et al. SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients. Clin Gastroenterol Hepatol. 2021;doi: 10.1016/j.cgh.2021.09.003.
Ruether, D. F., Schaub, G. M., Duengelhoef, P. M., Haag, F., Brehm, T. T., Fathi, A., Wehmeyer, M., Jahnke-Triankowski, J., Mayer, L., Hoffmann, A., Fischer, L., Addo, M. M., Lütgehetmann, M., Lohse, A. W., Schulze Zur Wiesch, J., & Sterneck, M. (2021). SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, . https://doi.org/10.1016/j.cgh.2021.09.003
Ruether, Darius F, et al. "SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association vol. (2021). doi: https://doi.org/10.1016/j.cgh.2021.09.003
Ruether DF, Schaub GM, Duengelhoef PM, Haag F, Brehm TT, Fathi A, Wehmeyer M, Jahnke-Triankowski J, Mayer L, Hoffmann A, Fischer L, Addo MM, Lütgehetmann M, Lohse AW, Schulze Zur Wiesch J, Sterneck M. SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients. Clin Gastroenterol Hepatol. 2021 Sep 09; doi: 10.1016/j.cgh.2021.09.003. Epub 2021 Sep 09. PMID: 34509643; PMCID: PMC8427908.
Copy Download .nbib Format: NLM
Showing 2593 to 2603 of 2603 entries